首站-论文投稿智能助手
典型文献
Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota
文献摘要:
This research aimed to investigate the antidiabetic activity, underlying mechanisms, and gut microbiota regulation of aloin. The insulin-resistant HepG2 (IR-HepG2) cell model and the type 2 diabetic (T2D) mouse model were successfully established using dexamethasone and a high-fat high-sucrose diet with low-dose streptozotocin, respectively. Aloin intervention increased glucose consumption and stimulated the activity of hexokinase and pyruvate dehydrogenase in IR-HepG2 cells. Additionally, it diminished the weight loss, reduced fasting blood glucose levels and hemoglobin A1c activity, and promoted glucose tolerance and fasting serum insulin activity in T2D mice. Histopathological analysis of the liver indicated hepatic protection by aloin. Additionally, aloin treatment inhibited the protein expression of c-Jun N-terminal kinases and activated that of IRS1/PI3K/Akt in the liver. Moreover, aloin modulated the bacterial community in the gut by raising the abundance of Bacteroidota and reducing the richness of Firmicutes, Proteobacteria, and Actinobacteriota. Thus, aloin ameliorated IR via activating IRS1/PI3K/Akt signaling pathway and regulating the gut microbiota, and it may be promising candidate as functional food for diabetic therapy.
文献关键词:
作者姓名:
Ruting Zhong;Lanbin Chen;Yuanyuan Liu;Shouxia Xie;Sumei Li;Bin Liu;Chao Zhao
作者机构:
College of Food Science,Fujian Agriculture and Forestry University,Fuzhou 350002,China;Department of Pharmacology,Shenzhen People's Hospital(The Second Clinical Medical College,Jinan University;The First Affi liated Hospital,Southern University of Science and Technology),Shenzhen 518020,Guangdong,China
引用格式:
[1]Ruting Zhong;Lanbin Chen;Yuanyuan Liu;Shouxia Xie;Sumei Li;Bin Liu;Chao Zhao-.Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota)[J].食品科学与人类健康(英文),2022(01):189-198
A类:
aloin,Aloin
B类:
Anti,effect,via,JNK,IRS1,PI3K,pathways,regulation,gut,microbiota,This,research,aimed,investigate,antidiabetic,activity,underlying,mechanisms,insulin,resistant,HepG2,model,type,T2D,mouse,were,successfully,established,using,dexamethasone,high,fat,sucrose,diet,low,dose,streptozotocin,respectively,intervention,increased,glucose,consumption,stimulated,hexokinase,pyruvate,dehydrogenase,cells,Additionally,diminished,weight,loss,reduced,fasting,blood,levels,hemoglobin,A1c,promoted,tolerance,serum,mice,Histopathological,analysis,liver,indicated,hepatic,protection,by,treatment,inhibited,protein,expression,Jun,terminal,kinases,activated,that,Akt,Moreover,modulated,bacterial,community,raising,abundance,Bacteroidota,reducing,richness,Firmicutes,Proteobacteria,Actinobacteriota,Thus,ameliorated,activating,signaling,regulating,may,promising,candidate,functional,food,therapy
AB值:
0.597908
相似文献
Co-fermented defatted rice bran alters gut microbiota and improves growth performance,antioxidant capacity,immune status and intestinal permeability of finishing pigs
Weifa Su;Zipeng Jiang;Cheng Wang;Yu Zhang;Tao Gong;Fengqin Wang;Mingliang Jin;Yizhen Wang;Zeqing Lu-Key Laboratory of Molecular Animal Nutrition,Ministry of Education,Zhejiang University,866 Yuhang Tang Road,Hangzhou,Zhejiang 310058,China;Key Laboratory of Animal Nutrition and Feed,Ministry of Agriculture,Zhejiang University,866 Yuhang Tang Road,Hangzhou,Zhejiang 310058,China;National Engineering Laboratory of Biological Feed Safety and Pollution Prevention and Control,Zhejiang University,866 Yuhang Tang Road,Hangzhou,Zhejiang 310058,China;Key Laboratory of Animal Nutrition and Feed Science of Zhejiang Province,Zhejiang University,866 Yuhang Tang Road,Hangzhou,Zhejiang 310058,China;College of Animal Science,Institute of Feed Science,Zhejiang University,866 Yuhang Tang Road,Hangzhou,Zhejiang 310058,China
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Functionalized gadofullerene ameliorates impaired glycolipid metabolism in type 2 diabetic mice
Jin Wu;Yingbo Chen;Xue Li;Liyuan Ran;Xiangdong Liu;Xiaoshuang Wang;Mingming Zhen;Shanshan Shao;Li Zeng;Chunru Wang;Bin Liang;Jiajun Zhao;Yingjie Wu-Shandong Provincial Hospital,Shandong Laboratory Animal Center,Science and Technology Innovation Center,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan,Shandong 250021,China;Institute for Genome Engineered Animal Models of Human Diseases,Dalian Medical University,Dalian,Liaoning 116044,China;Beijing National Laboratory for Molecular Sciences,Key Laboratory of Molecular Nanostructure and Nanotechnology,CAS Research/Education Center for Excellence in Molecular Sciences,Institute of Chemistry,Chinese Academy of Sciences,Beijing 100190,China;Center for Life Sciences,School of Life Sciences,Yunnan University,Kunming,Yunnan 650091,China;Department of Molecular Pathobiology,New York University College of Dentistry,New York 10010,USA
The gut microbial metabolite,3,4-dihydroxyphenylpropionic acid,alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice
Rui Li;Li Xie;Lei Li;Xiaojiao Chen;Tong Yao;Yuanxin Tian;Qingping Li;Kai Wang;Chenyang Huang;Cui Li;Yifan Li;Hongwei Zhou;Neil Kaplowitz;Yong Jiang;Peng Chen-Department of Pathophysiology,Guangdong Provincial Key Laboratory of Proteomics,School of Basic Medical Sciences,Southern Medical University,Guangzhou 510515,China;Microbiome Medicine Center,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Guangdong Provincial Key Laboratory of New Drug Screening,School of Pharmaceutical Science,Southern Medical University,Guangzhou 510515,China;Division of Hepatobiliopancreatic Surgery,Department of General Surgery,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;USC Research Center for Liver Disease,Department of Medicine,Keck School of Medicine of USC,Los Angeles,CA 90089,USA
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。